The agenda features a mix of clinical updates and lively debates on provocative scientific topics in the field, including emerging concepts and therapies in GI, rare tumors, cancers affecting the gastrointestinal tract, and much more.

May 17-18 | New York City

Available DatesRegister

Friday May 17, 2024

  • 9:15 AM – 9:25 AM

    Welcome

    • Co-Chair
      • Cathy EngMD, FACP, FASCO
      • Yelena JanjigianMD
  • 9:25 AM – 9:40 AM

    Session 1: Debate: Best Targeted Therapy for First-Line Gastroesophageal Cancer: PD-1 Inhibitors or Claudin-18.2 (CLDN18.2)? PD-1 INHIBITORS

    • Presenter
      • Ryan MoyMD, PhD
  • 9:40 AM – 9:55 AM

    Session 1: Debate: Best Targeted Therapy for First-Line Gastroesophageal Cancer: PD-1 Inhibitors or Claudin-18.2 (CLDN18.2)? CLDN18.2

    • Presenter
      • Samuel CytrynMD
  • 9:55 AM – 10:05 AM

    Session 1: Debate: Best Targeted Therapy for First-Line Gastroesophageal Cancer: PD-1 Inhibitors or Claudin-18.2 (CLDN18.2)? DISCUSSION

    • Moderator
      • Cathy EngMD, FACP, FASCO
      • Yelena JanjigianMD
    • Panelist
      • Ryan MoyMD, PhD
      • Samuel CytrynMD
  • 10:05 AM – 10:20 AM

    Session 2: Debate: MSI Tumors: Does Anatomic Location Affect the Management? Yes vs No: YES

    • Presenter
      • Lakshmi RajdevMD, MS
  • 10:20 AM – 10:35 AM

    Session 2: Debate: MSI Tumors: Does Anatomic Location Affect the Management? Yes vs No: NO

    • Presenter
      • Nataliya UbohaMD, PhD
  • 10:35 AM – 10:45 AM

    Session 2: Debate: MSI Tumors: Does Anatomic Location Affect the Management? Yes vs No: DISCUSSION

    • Moderator
      • Cathy EngMD, FACP, FASCO
      • Yelena JanjigianMD
    • Panelist
      • Lakshmi RajdevMD, MS
      • Nataliya UbohaMD, PhD
  • 10:45 AM – 11:15 AM

    Break

  • 11:15 AM – 11:30 AM

    Session 3: Debate: Management of Gastric Cancer With Limited Peritoneal Carcinomatosis - Cytoreduction and HIPEC for All: Yes vs No - YES

    • Presenter
      • Yanghee WooMD, FACS
  • 11:30 AM – 11:45 AM

    Session 3: Debate: Management of Gastric Cancer With Limited Peritoneal Carcinomatosis - Cytoreduction and HIPEC for All: Yes vs No - NO

    • Presenter
      • Nataliya UbohaMD, PhD
View Full Agenda

Highlights

Colorectal Cancers

Gastroesophageal Cancer

Gastrointestinal Cancer: Emerging Concepts & Therapies

Hepatobiliary Cancers

Pancreatic Cancer

Rare Tumors

Targeted Approaches in Gastric Cancers and Other GI Malignancies